Cardiovascular Risk Which Needs Primary Or Secundary Prevention With Statins clinical trials

Explore recruiting cardiovascular risk which needs primary or secundary prevention with statins clinical trials.

Also recruiting in Europe

Cardiovascular Risk Which Needs Primary Or Secundary Prevention With Statins trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Pragmatic clinical trial to assess the utility of SLCO1B1, ABCG2, and CYP2C9 preepmtive genotyping and pharmacogenetics training on the incidence of musculoskeletal adverse reactions in patients treated with statins in primary and specialized care.

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Cardiovascular Risk Which Needs Primary Or Secundary Prevention With Statins trials by city

Cardiovascular Risk Which Needs Primary Or Secundary Prevention With Statins in Toronto Cardiovascular Risk Which Needs Primary Or Secundary Prevention With Statins in Vancouver Cardiovascular Risk Which Needs Primary Or Secundary Prevention With Statins in Montreal Cardiovascular Risk Which Needs Primary Or Secundary Prevention With Statins in Calgary Cardiovascular Risk Which Needs Primary Or Secundary Prevention With Statins in Edmonton Cardiovascular Risk Which Needs Primary Or Secundary Prevention With Statins in Ottawa Cardiovascular Risk Which Needs Primary Or Secundary Prevention With Statins in Winnipeg Cardiovascular Risk Which Needs Primary Or Secundary Prevention With Statins in Quebec City Cardiovascular Risk Which Needs Primary Or Secundary Prevention With Statins in Hamilton Cardiovascular Risk Which Needs Primary Or Secundary Prevention With Statins in Kitchener Cardiovascular Risk Which Needs Primary Or Secundary Prevention With Statins in London Cardiovascular Risk Which Needs Primary Or Secundary Prevention With Statins in Halifax Cardiovascular Risk Which Needs Primary Or Secundary Prevention With Statins in New York Cardiovascular Risk Which Needs Primary Or Secundary Prevention With Statins in Los Angeles Cardiovascular Risk Which Needs Primary Or Secundary Prevention With Statins in Chicago Cardiovascular Risk Which Needs Primary Or Secundary Prevention With Statins in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease